Navigation Links
Gabapentin Shown Effective for Fibromyalgia Pain

Diseases (NIAMS), a part of the Department of Health and Human Services National Institutes of Health, is to support research into the causes, treatment and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in these diseases. For more information about NIAMS, call the information clearinghouse at (301) 495-4484 or (877) 22-NIAMS (free call) or visit the NIAMS website at http://www.niams.nih.gov.

The National Institutes of Health (NIH) The Nation's Medical Research Agency includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

CONTACT:
Ray Fleming
301-496-8190

--------------------------------------------------------------------------------
Arnold, LM et al. Gabapentin in the treatment of fibromyalgia; a randomized, double-blind, placebo-controlled multicenter trial. Arthritis Rheum. 2007; 56: 1336-1344.
--------------------------------------------------------------------------------


'"/>




Page: 1 2 3

Related medicine technology :

1. RTA 402 Shown to Protect Animals Against Toxicities of Standard Cancer Treatments
2. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
3. CEL-SCIS CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals
4. Efficacy and Safety Profile of Basileas Alitretinoin for Severe Refractory Chronic Hand Eczema Confirmed by Data Shown at European Dermatology Congress
5. Innovative Cancer Drug MabThera Again Shown To Improve Survival Rates In Patients With Lymphoma
6. RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds Significant Promise for Treating Breast Cancer
7. Accelreon Pharmas ACE-031Shown to Increase Muscle Mass in Preclinical Studies
8. Cethromycin Shown Effective Against Anthrax in Study
9. CEL-SCIs Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gabapentin Shown Effective for Fibromyalgia Pain
(Date:12/3/2009)..., SAN DIEGO, Dec. 3 B...today that it has entered into a new lease with Re... approximately 131,000 square feet of additional, ...he Landmark at Eastview campus in Tarrytown, New Y...lease of additional space was completed approximat...
(Date:12/3/2009)... , WILMINGTON, Del., Dec. 3 Pa...pharmaceutical risk management and optimal medicat...c. 9, on the FDA,s draft guidance on REMS - Risk E...mplications for REMS lifecycle management. Dr. Ga...an expert on REMS and risk management programs, wi...
(Date:12/3/2009)... , FORT WORTH, Texas, Dec. 3 /PRNewswire...c. (OTC Bulletin Board: WNDM), a rapidly growing p...oday an agreement with the Health Industry Represe...sive independent sales and marketing representativ... product within the U.S. ,, HIRA will market a...
Breaking Medicine Technology:BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Scientists decipher missing piece of first responder DNA repair machine 58671 1Scientists decipher missing piece of first responder DNA repair machine 58671 2Scientists decipher missing piece of first responder DNA repair machine 58671 3Meeting highlights the role of molecular imaging biomarkers in clinical research and therapeutics 58668 1Meeting highlights the role of molecular imaging biomarkers in clinical research and therapeutics 58668 2Frozen assets 3A NIAID researchers turn to unique resource for clues to norovirus evolution 10218 1Frozen assets 3A NIAID researchers turn to unique resource for clues to norovirus evolution 10218 2Frozen assets 3A NIAID researchers turn to unique resource for clues to norovirus evolution 10218 3
...ponse Observed Across All Subtypes of AML, Includi...ISCO, Dec. 8 Eisai Corporation of North America t...ng a five-day dosing regimen of Dacogen(R) (decita...), the most common form of leukemia. The study in...imited options due to comorbidities and are typica...
...ISVILLE, Ky., Dec. 8 Last week, at the Society fo...etrix announced preliminary,results from a clinica...Alzheimer,s disease. The study was performed with...ky,s Sanders-Brown Center for Aging. , The ... (ERP) to record,brain activity while the patient ...
Other Medicine Technology:Dacogen(R) (decitabine for injection) Data Presented on a Phase II Clinical Trial in Elderly Patients with Acute Myeloid Leukemia (AML) 2Dacogen(R) (decitabine for injection) Data Presented on a Phase II Clinical Trial in Elderly Patients with Acute Myeloid Leukemia (AML) 3Dacogen(R) (decitabine for injection) Data Presented on a Phase II Clinical Trial in Elderly Patients with Acute Myeloid Leukemia (AML) 4Neuronetrix Announces Preliminary Alzheimer's Study Results at the Society for Neuroscience Conference 2
(Date:12/4/2009)... Tender Corp., a leading manufacturer of over-the-...ned to enhance consumers’ quality of life, t...d American Podiatric Medical Association (APMA) Se... HealthiFeet®. , (PR...anufacturer of over-the-counter topical cream and ...
(Date:12/4/2009)...nd., Dec. 4 Hill-Rom Hol...cal 2010 first quarter dividend of $0.1025 per sha... of Directors on December 3, 2009, and is payable ... of December 17, 2009. ,, ABOUT HILL-ROM H...ide manufacturer and provider of medical technolog...
(Date:12/4/2009)...n., Dec. 4 MedClean Tech...nounced the Company has entered into a preferred s... LLC, a Delaware limited liability company, doing...LC. Pursuant to the Purchase Agreement, MedClean w...The Company agreed to sell up to 750 shares of its...
(Date:12/4/2009)...Claim That Health Reform Bills Will Increase Defic.../ -- Despite claims that the pending health reform...er lets Medicare savings take effect, Congress has...t enacted in the past two decades to take effect a...he Center on Budget and Policy Priorities shows. ,...
(Date:12/4/2009)...ec. 4 The National Cancer Institut...act to Fred Hutchinson Cancer Research Center to b...ormation Service Contact Center. ,, The move wi...early tripling the size of its current CIS workfor...onal, which is scheduled for March 15, 2010. The S...
Breaking Medicine News(10 mins):Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 3Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 4Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 2Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 3Health News:Congress Has Allowed Most Previous Medicare Cuts to Take Effect, New Study Shows 2Health News:Congress Has Allowed Most Previous Medicare Cuts to Take Effect, New Study Shows 3Health News:Congress Has Allowed Most Previous Medicare Cuts to Take Effect, New Study Shows 4Health News:Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service 2
... that volunteers distributing condoms in the provi... despite the soaring rates of teenage pregnancies/... hand over contraceptives to under-16s as a child ...hairman of the BMA's Scottish GP committee. He add...
...suffer from disrupting sleep and increased blood p...und that breathing masks are very helpful// in giv...educe their blood pressure significantly. The s...sical health, and this study shows once again that...
...h research it was found that amino acid, l-cystein...ries about 80 % of the cancers occur// in the mout...t is smoking and alcohol drinking. This results in...lsinki and Helsinki University Hospital, Finland, ...
...esearch report which was published by SAGE Publica...their doctors did not have a similarity// in their...ity. This report was published in the Journal of t...initiation of treatment, the various goals of trea...
...e published in The Lancet, Rainer Gross, PhD, UNIC...an for academic affairs// at the Friedman School o..., have debated five important pointers about world...in children usually found in the middle of a famin...
... that was presented yesterday at Digestive Disease...py with new compounds can sustain relief for these...n to inflammation. These studies are conducted to ...nd Crohn's disease may vary in function and their ...
Other Medicine News:Health News:Sleep Apnea Patients Benefit from Breathing Mask 2Health News:Finnish research: Cysteine Chewing Gum as a cure for cancers of the mouth 2Health News:Understanding World Hunger and Malnutrition 2Health News:Understanding World Hunger and Malnutrition 3Health News:New compounds Help Sustain relief For Patients With Symptoms of Bowel Disorders 2Health News:New compounds Help Sustain relief For Patients With Symptoms of Bowel Disorders 3
Premier Lock 'n Roll Drainable Pouch, Pre-Sized Convex Flextend Skin Barrier, with Tape
Premier Lock 'n Roll Drainable Pouch with Filter, Cut-to-Fit SoftFlex Skin Barrier
Premier High Output Pouch Non-Sterile
Premier Closed Pouch with Filter, Cut-to-Fit SoftFlex Skin Barrier
Medicine Products: